Literature DB >> 19128835

Global effects of inorganic arsenic on gene expression profile in human macrophages.

Emilie Bourdonnay1, Claudie Morzadec, Lydie Sparfel, Marie-Dominique Galibert, Stéphane Jouneau, Corinne Martin-Chouly, Olivier Fardel, Laurent Vernhet.   

Abstract

Inorganic arsenic, a major environmental contaminant, exerts immunosuppressive effects towards human cells. We previously demonstrated that relevant environmental concentrations of inorganic arsenic altered morphology and functions of human primary macrophages, suggesting interference with macrophage differentiation program. The goal of this study was to determine global effect of low concentrations of arsenic trioxide (As(2)O(3)) on gene expression profile in human primary macrophages, in order to identify molecular targets of inorganic arsenic, especially those relevant of macrophage differentiation process. Using a pan-genomic microarray, we demonstrate that exposure of human blood monocyte-derived macrophages to 1microM As(2)O(3) for 72h, a non-cytototoxic concentration, results in up-regulation of 32 genes and repression of 91 genes. Among these genes, 26 are specifically related to differentiation program of human macrophages. Particularly, we validated that As(2)O(3) strongly alters expression of MMP9, MMP12, CCL22, SPON2 and CXCL2 genes, which contribute to major macrophagic functions. Most of these metalloid effects were reversed when As(2)O(3)-treated macrophages were next cultured in arsenic-free medium. We also show that As(2)O(3) similarly regulates expression of this macrophagic gene subset in human alveolar macrophages, the phenotype of which closely resembles that of blood monocyte-derived macrophage. In conclusion, our study demonstrates that environmentally relevant concentrations of As(2)O(3) impair expression of macrophage-specific genes, which fully supports interference of metalloid with differentiation program of human macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19128835     DOI: 10.1016/j.molimm.2008.08.268

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  A time-series analysis of altered histone H3 acetylation and gene expression during the course of MMAIII-induced malignant transformation of urinary bladder cells.

Authors:  Jinqiu Zhu; Jie Wang; Xushen Chen; Maria Tsompana; Daniel Gaile; Michael Buck; Xuefeng Ren
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

2.  Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood.

Authors:  Molly L Kile; E Andres Houseman; Andrea A Baccarelli; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mostofa; Andres Cardenas; Robert O Wright; David C Christiani
Journal:  Epigenetics       Date:  2014-02-13       Impact factor: 4.528

Review 3.  Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Br J Pharmacol       Date:  2020-03-12       Impact factor: 8.739

4.  Arsenic responsive microRNAs in vivo and their potential involvement in arsenic-induced oxidative stress.

Authors:  Xuefeng Ren; Daniel P Gaile; Zhihong Gong; Wenting Qiu; Yichen Ge; Chuanwu Zhang; Chenping Huang; Hongtao Yan; James R Olson; Terrance J Kavanagh; Hongmei Wu
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-24       Impact factor: 4.219

Review 5.  Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms.

Authors:  Pablo Pánico; Myrian Velasco; Ana María Salazar; Arturo Picones; Rosa Isela Ortiz-Huidobro; Gabriela Guerrero-Palomo; Manuel Eduardo Salgado-Bernabé; Patricia Ostrosky-Wegman; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

6.  Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response.

Authors:  Carolina Ramírez; Yira Díaz-Toro; Jair Tellez; Tiago M Castilho; Ricardo Rojas; Nicholas A Ettinger; Irina Tikhonova; Neal D Alexander; Liliana Valderrama; Janet Hager; Mary E Wilson; Aiping Lin; Hongyu Zhao; Nancy G Saravia; Diane McMahon-Pratt
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

7.  Ubiquinol decreases monocytic expression and DNA methylation of the pro-inflammatory chemokine ligand 2 gene in humans.

Authors:  Alexandra Fischer; Simone Onur; Constance Schmelzer; Frank Döring
Journal:  BMC Res Notes       Date:  2012-10-01

Review 8.  An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis.

Authors:  Xuefeng Ren; Cliona M McHale; Christine F Skibola; Allan H Smith; Martyn T Smith; Luoping Zhang
Journal:  Environ Health Perspect       Date:  2010-08-02       Impact factor: 9.031

9.  Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.

Authors:  Serkan Sertel; Margaret Tome; Margaret M Briehl; Judith Bauer; Kai Hock; Peter K Plinkert; Thomas Efferth
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

10.  Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010).

Authors:  Andres Cardenas; Ellen Smit; E Andres Houseman; Nancy I Kerkvliet; Jeffrey W Bethel; Molly L Kile
Journal:  Environ Health Perspect       Date:  2015-01-30       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.